Related Experiment Video
Updated: Feb 13, 2026

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
The Evolving Landscape of Brain Metastasis
Manuel Valiente1, Manmeet S Ahluwalia2, Adrienne Boire3
1Brain Metastasis Group, Spanish National Cancer Research Center (CNIO), Melchor Fernández Almagro 3, Madrid, Spain.
Abstract:
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.
Insights
Cancer metastasis to the brain causes severe disability and death. New research in targeted therapy and immunotherapy offers hope for improved treatments for secondary brain tumors.
Area of Science:
- Neuro-oncology
- Translational Cancer Research
Background:
- Brain metastasis, the spread of cancer to the brain, leads to significant neurologic disability and mortality.
- Current therapeutic strategies for brain metastases are predominantly palliative, highlighting an unmet clinical need for more effective treatments.
Purpose of the Study:
- To provide a comprehensive overview of contemporary research and management strategies for secondary brain tumors.
- To highlight recent advances in understanding and treating brain metastasis.
Main Methods:
- Review of preclinical and clinical studies.
- Synthesis of recent findings across epidemiology, genetics, tumor microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis.
Main Results:
- Recent experimental and clinical advances are challenging the historically poor long-term outcomes for patients with brain metastases.
- Emerging research indicates progress in targeted therapies and immunotherapies for managing secondary brain tumors.
Conclusions:
- Despite the challenges, the landscape of brain metastasis treatment is evolving with promising new therapeutic avenues.
- Continued research into the multifaceted aspects of brain metastasis is crucial for developing improved clinical interventions.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Brain Waves
Organization of the Brain
Hindbrain
The hindbrain, located at the base of the brain, plays a vital role in regulating automatic processes that sustain life. It includes the medulla oblongata, which is essential for...
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
The Blood-brain Barrier
Anatomy of the Brain: Ventricles

